National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Triploid Syndrome is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Chromosome Triploidy Syndrome
- Triploidy Syndrome
- 3n Syndrome
- Diploid/Triploid Mixoploidy
- 2n/3n Mixoploidy
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Down Syndrome
- Chromosome 11, Monosomy 11q
- 18p Syndrome
Triploid Syndrome is an extremely rare chromosomal disorder. Individuals with triploid syndrome have three of every chromosome for a total of sixty-nine rather than the normal forty-six chromosomes. Babies with Triploid Syndrome usually are lost through early miscarriage. However, some infants have been born and survived as long as five months. Affected infants are usually small and have multiple birth defects. Those that survive are usually mosaic, meaning that some cells have the normal number of 46 chromosomes and some cells have a complete extra set of chromosomes.
Triploid Syndrome may include larger than normal size placenta, lack of prenatal skeletal growth, widely spaced eyes (ocular hypertelorism), low nasal bridge, low-set malformed ears and a smaller than normal sized jaw. The third and fourth fingers of the hands may be connected and the hands may have unusual simian creases. The infant may have congenital heart defects and genital abnormalities may be present in males. There may be abnormal brain development, lack of development of the adrenal glands and cystic kidneys. Growth of the brain or spinal cord outside of the body (neural tube defects), openings in the abdominal wall, an unusually shaped skull and cleft lip and/or palate have also been observed. There may also be liver and gallbladder deformities, twisted colon and finger and toe deformities. Individuals who are mosaic will survive longer than those with complete triploidy but usually have mental retardation.
The pregnant mother carrying a triploid fetus sometimes experiences extremes of high blood pressure (hypertension), swelling (edema), and excretion of albumin in the urine (albuminuria). This condition is called toxemia or preeclampsia. Triploidy is frequently diagnosed in pregnancies in which there is a cystic placenta (partial mole). The Triploid Syndrome has been associated with pregnancies that occur soon after oral contraceptives are discontinued or after long menstrual cycles. Triploidy has been reported in conceptions that occurred following in vitro fertilization and in conceptions after a history of repeated miscarriages.
Triploid Syndrome is caused by a complete extra set of chromosomes. The triplication of the chromosomes is most often caused by fertilization of an egg by two sperm. Triploidy can also be caused by fertilization of an egg by a sperm that has an extra set of chromosomes or fertilization of an egg that has an extra set of chromosomes by a normal sperm. This disorder does not run in families and is not associated with maternal or paternal age.
Symptoms of the following disorders are caused by duplication, triplication or deletion of chromosomes:
Trisomies are very rare genetic disorders characterized by a triple chromosome. The most common symptom of the trisomies is mental retardation. Chromosomes are found in the nucleus of all body cells. They carry the genetic characteristics of each individual. Pairs of human chromosomes are numbered from 1 through 22, with an unequal 23rd pair of X and Y chromosomes for males, and two X chromosomes for females. People with a Trisomy have an extra chromosome added to one of the normal pairs. The triplication of the chromosome may be partial, either an extra short arm (p+) or an extra long arm (q+). Defects are classified by the name of the abnormal chromosome pair and which portion of the chromosome is affected. (For more information on this disorder, choose "Trisomy" as your search term in the Rare Disease Database.)
Down Syndrome is the most common and readily identifiable genetic condition caused by a chromosomal abnormality. One additional chromosome is present. Children with Down Syndrome have some degree of mental retardation. That can range from mild to profound. However, most children with Down Syndrome function in the mild to moderate range. Many of the children can be educated in the public schools, learn basic academic and pre-vocational skills with special training, and perform many daily living activities independently. (For more information on this disorder, choose "Down" as your search term in the Rare Disease Database.)
Chromosome 11, Monosomy 11q (Jacobsen Syndrome) is a rare genetic disorder affecting the long arm of chromosome 11. The disorder may be characterized by a narrow protruding forehead, eye problems, abnormally shaped nose and mouth and mental retardation. This syndrome is caused by a deletion on the long arm (q) of chromosome 11. The severity and type of abnormality depends upon the size and location of the missing chromosome piece. The cause of the chromosome break itself is unknown. (For more information on this disorder, choose "Chromosome 11, Monosomy 11q" as your search term in the Rare Disease Database.)
18p Syndrome is a deletion of the short arm (p) of chromosome 18. It is characterized by unusual facial features and mild to severe mental retardation. This syndrome may also include growth deficiency, diminished muscle tension and a smaller than normal sized brain. There may also be behavior problems and delayed speech. (For more information on this disorder, choose "18p" as your search term in the Rare Disease Database.)
Triploid syndrome can be diagnosed thorough cytogenetic (chromosome) analysis on a blood specimen. It can be diagnosed prenatally through cytogenetic analysis of cells obtained through amniocentesis or chorionic villus sampling. Abnormal levels of specific maternal blood proteins such as alpha-fetoprotein, human chorionic gonadotropin, estriol and pregnancy-assisted plasma protein-A have been associated with an increased risk for triploidy.
Treatment of triploid syndrome is symptomatic and supportive.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Jones KL, Ed. Smith's Recognizable patterns of Human Malformation. 4th ed. W.B. Saunders Company. 1998:32-35.
Doshi N, et al. Morphologic anomalies in triploid liveborn fetuses. Hum Path. 1983;14(4):716-723.
Beatty RA. The origin of human triploidy: An integration of qualitative and quantitative evidence. Ann Hum Genet (Cambridge). 1978;41:229-314.
Graham JM, et al. Triploidy: Pregnancy complications and clinical findings in seven cases. Prenat Diag. 1989;9:409-19.
Wertelecki W, et al. The clinical syndrome of triploidy. Obst Gyn. 1976;47:69-76.
Cerakushansky G, et al. Diploid/triploid mosacicism: Further delination of the phenotype. Am J Med Genet. 1994;52:399-401.
Edwards MJ, et al. Clinical features of diploid/polyploid mixoploidy in older individuals. Pediat Res. 1989;25:76.
Graham JM, et al. Diploid-Triploid mixoploidy: Clinical and cytogenetic aspects. Pediatrics. 1981;68:23-8.
Angell RR, et al. Chromosome studies in human in vitro fertilization. Hum Genet. 1986;72:333-339.
Benn PA, et al. Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement. Prenat Diag. 2001;21:680-686.
Carp H, et al. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001;75:678-682.
Zaragoza MV et al. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet. 2000;66:1807-1820.
UNIQUE - Rare Chromosome Disorder Support Group
The Rare Chromosome Disorder Support Group
G1 The Stables
Station Road West, Oxted
Surrey, RH8 9EE
Email: firstname.lastname@example.org or email@example.com
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 5/21/2008
Copyright 1989, 2003 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.